# Bayesian Health

> Clinical AI platform for real-time patient risk stratification and triage in hospitals.

## Why it is interesting

Johns Hopkins spinout led by Suchi Saria; peer-reviewed outcomes show faster sepsis detection with high clinician adoption — rare evidence bar for inpatient AI.

## Profile

- **Stage:** series-a
- **Status:** private
- **Industries:** healthtech, biotech-life-sciences
- **Coverage:** full
- **Last updated:** 2026-07-24

## Key facts

- Series A (Jul 2021): $15M led by a16z Bio + Health (a16z announcement)
- Co-investors not in VCT directory: Health2047 Capital Partners, Lifeforce Capital, Catalio Capital Management
- Source: https://a16z.com/announcement/investing-in-bayesian-health/
- VCT directory co-investors: none mapped (non-directory syndicates noted above); reviewed 2026-07-24

## Investors in our directory

- https://venturecapitaltracker.com/fund/andreessen-horowitz

---
Source: https://venturecapitaltracker.com/startup/bayesian-health